BXCL-702

N/A

Report date: 2024/04/19 11:57:32
NME

Base Information

Drug NameBXCL-702
Drug Alias NameBXCL-702
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsSolid tumoursLymphoma, Large B-Cell, DiffuseLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInveni
China Registration ClassN/A

Develop Information

Active CompaniesBioxcel Therapeutics Inc
Inactive CompaniesInveni
Active IndicationsSolid tumours
Inactive IndicationsLymphoma, Large B-Cell, DiffuseLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A